| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |